Xu, D., Cai, Y., Tang, L., Han, X., Gao, F., Cao, H., . . . Kapranov, P. (2020). A CRISPR/Cas13-based approach demonstrates biological relevance of vlinc class of long non-coding RNAs in anticancer drug response. Sci Rep.

Xu, Dongyang, Ye Cai, Lu Tang, Xueer Han, Fan Gao, Huifen Cao, Fei Qi, a Philipp Kapranov. "A CRISPR/Cas13-based Approach Demonstrates Biological Relevance of Vlinc Class of Long Non-coding RNAs in Anticancer Drug Response." Sci Rep 2020.

Xu, Dongyang, et al. "A CRISPR/Cas13-based Approach Demonstrates Biological Relevance of Vlinc Class of Long Non-coding RNAs in Anticancer Drug Response." Sci Rep 2020.